ClearPoint Neuro (CLPT) Capital Expenditures Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 252.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 252.46% |
| Dec 31, 2025 | -81.37% |
| Sep 30, 2025 | 1,558.33% |
| Dec 31, 2024 | 1,152.38% |
| Sep 30, 2024 | -94.89% |
| Dec 31, 2023 | -46.15% |
| Sep 30, 2023 | 240.58% |
| Jun 30, 2023 | 325.00% |
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | 2.63% |
| Sep 30, 2022 | -44.80% |
| Jun 30, 2022 | 317.14% |
| Mar 31, 2022 | 72.50% |
| Dec 31, 2019 | -122.65% |
| Mar 31, 2016 | 1,070.29% |
| Sep 30, 2015 | 940.63% |
| Jun 30, 2015 | -75.17% |
| Mar 31, 2015 | 177.62% |
| Dec 31, 2014 | 4,334.34% |
| Sep 30, 2014 | -65.10% |
| Jun 30, 2014 | -93.76% |
| Mar 31, 2014 | -70.07% |
| Dec 31, 2013 | -97.59% |
| Sep 30, 2013 | 112.04% |
| Jun 30, 2013 | -40.43% |
| Mar 31, 2013 | 76.64% |
| Dec 31, 2012 | 262.03% |
| Sep 30, 2012 | -43.72% |